NTAGI for reducing Covid booster dose gap from 9 to 6 months

Tribune News Service

Updated At : 02:00 AM Jun 17, 2022 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits

Yearly Premium ₹999 ₹349/Year

Yearly Premium $49 $24.99/Year

New Delhi, June 16

India’s apex vaccine strategy recommending body, the National Technical Advisory Group on Immunisation in its meeting on Thursday recommended reducing the gap between the second dose of the Covid vaccine and the booster dose from the current nine to six months.

The precaution dose uptake has been very low in India with just 42 of even the eligible elderly covered so far.

NTAGI did not make any recommendations on allowing a heterologous (mixed) booster dose and said more evidence was needed to allow a vaccine different from the one used in primary two dose schedule to be used as a booster.

NTAGI reviewed CMC Vellore study on allowing a different vaccine as a booster but didn’t recommend anything.

The health ministry will take a call on NTAGI proposal on cutting the booster dose gap.

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Unlock Exclusive Insights with The Tribune Premium

Suggested Articles